Amring Pharmaceuticals Inc 2023-06-21 Health moderate FDA
Health · FDA · Recall #FDA-D-0871-2023
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only,… Recall
Issued June 21, 2023 · Amring Pharmaceuticals Inc
In June 2023, Amring Pharmaceuticals Inc recalled the Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only,…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
What you should do
- 1 Stop using Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amring Pharmaceuticals Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amring Pharmaceuticals Inc
- Category
- Health
- Recall date
- June 21, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-0871-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Amring Pharmaceuticals Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.